PRE

Prenetics Global Limited

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Limited (PRE) is scored daily on Deltasharpe Prism against Consumer Defensive sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 C+ (2.7) A (4.4) B- (3.0) B (3.4) C+ (2.6) B (3.2)
2026-11-07 C+ (2.7) A (4.4) B- (3.1) B+ (3.6) C+ (2.5) B (3.3)
2026-10-31 C+ (2.5) A (4.4) B- (3.0) B+ (3.8) C (2.5) B (3.2)
2026-10-24 C+ (2.6) A (4.3) B- (3.0) B+ (3.7) C (2.3) B (3.2)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe